CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 217 filers reported holding CHEMOCENTRYX INC in Q3 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,550,000 | +111.5% | 30,004 | +1.4% | 0.01% | +120.0% |
| Q2 2022 | $733,000 | +9.1% | 29,580 | +10.3% | 0.01% | +25.0% |
| Q1 2022 | $672,000 | -35.7% | 26,806 | -6.6% | 0.00% | -20.0% |
| Q4 2021 | $1,045,000 | +106.9% | 28,694 | -2.9% | 0.01% | +66.7% |
| Q3 2021 | $505,000 | +24.7% | 29,552 | -2.3% | 0.00% | +200.0% |
| Q2 2021 | $405,000 | -72.7% | 30,254 | +4.7% | 0.00% | -80.0% |
| Q1 2021 | $1,481,000 | -17.0% | 28,901 | +0.3% | 0.01% | -28.6% |
| Q4 2020 | $1,785,000 | +9.8% | 28,825 | -2.8% | 0.01% | -12.5% |
| Q3 2020 | $1,625,000 | +3.8% | 29,652 | +9.0% | 0.01% | 0.0% |
| Q2 2020 | $1,565,000 | +61.5% | 27,201 | +12.8% | 0.01% | +60.0% |
| Q1 2020 | $969,000 | -4.0% | 24,119 | -5.5% | 0.01% | +25.0% |
| Q4 2019 | $1,009,000 | +479.9% | 25,512 | -0.8% | 0.00% | +300.0% |
| Q3 2019 | $174,000 | -27.8% | 25,727 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $241,000 | +21.1% | 25,907 | +80.8% | 0.00% | 0.0% |
| Q1 2019 | $199,000 | +23.6% | 14,327 | -3.1% | 0.00% | 0.0% |
| Q4 2018 | $161,000 | -14.4% | 14,790 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $188,000 | 0.0% | 14,904 | +4.4% | 0.00% | 0.0% |
| Q2 2018 | $188,000 | -12.6% | 14,278 | -9.6% | 0.00% | 0.0% |
| Q1 2018 | $215,000 | +117.2% | 15,795 | -5.1% | 0.00% | – |
| Q4 2017 | $99,000 | -18.2% | 16,644 | +1.7% | 0.00% | – |
| Q3 2017 | $121,000 | -14.8% | 16,364 | +8.1% | 0.00% | -100.0% |
| Q2 2017 | $142,000 | +47.9% | 15,141 | +14.7% | 0.00% | – |
| Q1 2017 | $96,000 | +5.5% | 13,202 | +7.6% | 0.00% | – |
| Q4 2016 | $91,000 | -99.9% | 12,269 | -0.3% | 0.00% | – |
| Q3 2016 | $74,298,000 | +34.7% | 12,301 | +0.1% | 0.00% | – |
| Q2 2016 | $55,151,000 | +34.5% | 12,283 | -25.0% | 0.00% | – |
| Q1 2016 | $41,000,000 | -69.2% | 16,383 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $133,000,000 | +134243.4% | 16,383 | -0.2% | 0.00% | – |
| Q3 2015 | $99,000 | -99.9% | 16,412 | +0.1% | 0.00% | -100.0% |
| Q2 2015 | $134,914,000 | +3.9% | 16,393 | -4.7% | 0.00% | 0.0% |
| Q1 2015 | $129,852,000 | +10.5% | 17,199 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $117,469,000 | +46.0% | 17,199 | -3.8% | 0.00% | – |
| Q3 2014 | $80,465,000 | -23.1% | 17,881 | -0.1% | 0.00% | – |
| Q2 2014 | $104,674,000 | -5.6% | 17,893 | +7.0% | 0.00% | -100.0% |
| Q1 2014 | $110,827,000 | +17.3% | 16,716 | +2.5% | 0.00% | – |
| Q4 2013 | $94,464,000 | +3.1% | 16,315 | -1.0% | 0.00% | – |
| Q3 2013 | $91,618,000 | +73.4% | 16,478 | +341.1% | 0.00% | – |
| Q2 2013 | $52,827,000 | – | 3,736 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |